Jane E. Brock

18.4k total citations
42 papers, 727 citations indexed

About

Jane E. Brock is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jane E. Brock has authored 42 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Cancer Research and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Jane E. Brock's work include Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (10 papers) and HER2/EGFR in Cancer Research (8 papers). Jane E. Brock is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (10 papers) and HER2/EGFR in Cancer Research (8 papers). Jane E. Brock collaborates with scholars based in United States, Rwanda and Ireland. Jane E. Brock's co-authors include Susan C. Lester, Lydia E. Pace, Lawrence N. Shulman, Yehoda M. Martei, Deborah Dillon, Jay R. Harris, Mehra Golshan, Yu‐Hui Chen, Eric P. Winer and William T. Barry and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.

In The Last Decade

Jane E. Brock

42 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane E. Brock United States 16 369 315 219 115 104 42 727
Laura Ferrari Italy 11 307 0.8× 299 0.9× 93 0.4× 125 1.1× 157 1.5× 26 669
Benita Kiat Tee Tan Singapore 18 531 1.4× 531 1.7× 310 1.4× 195 1.7× 200 1.9× 76 1.1k
Elizabeth M. Azzato United States 16 396 1.1× 360 1.1× 142 0.6× 237 2.1× 58 0.6× 43 956
G. Schubert-Fritschle Germany 16 485 1.3× 185 0.6× 99 0.5× 217 1.9× 168 1.6× 58 847
Renjian Jiang United States 16 406 1.1× 151 0.5× 80 0.4× 220 1.9× 209 2.0× 61 689
Mary Cianfrocca United States 14 869 2.4× 533 1.7× 279 1.3× 239 2.1× 95 0.9× 31 1.3k
Frank Peters Netherlands 13 425 1.2× 236 0.7× 81 0.4× 323 2.8× 70 0.7× 32 754
Sung Hoon Sim South Korea 18 493 1.3× 230 0.7× 115 0.5× 325 2.8× 131 1.3× 81 1.0k
Thomas J. Semrad United States 15 395 1.1× 162 0.5× 99 0.5× 237 2.1× 122 1.2× 51 890
Dimitri Korol Switzerland 16 322 0.9× 115 0.4× 104 0.5× 162 1.4× 60 0.6× 42 742

Countries citing papers authored by Jane E. Brock

Since Specialization
Citations

This map shows the geographic impact of Jane E. Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Brock more than expected).

Fields of papers citing papers by Jane E. Brock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Brock. The network helps show where Jane E. Brock may publish in the future.

Co-authorship network of co-authors of Jane E. Brock

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Brock. A scholar is included among the top collaborators of Jane E. Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Brock. Jane E. Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Sun, Ellen X., et al.. (2020). Cross-Residency Radiologic/Pathologic Correlation Curriculum: Teaching Correlation of Surgical Specimens With Imaging. Academic Pathology. 7. 1534939386–1534939386. 3 indexed citations
4.
Brock, Jane E., Elizabeth A. Morgan, Yehoda M. Martei, et al.. (2020). Harmonization of the Essentials: Matching Diagnostics to Treatments for Global Oncology. JCO Global Oncology. 6(6). 1352–1356. 3 indexed citations
5.
Jencks, Stephen F., et al.. (2019). Safety-Net Hospitals, Neighborhood Disadvantage, and Readmissions Under Maryland's All-Payer Program. Annals of Internal Medicine. 171(2). 91–98. 48 indexed citations
6.
Sanders, Mary Ann, Jane E. Brock, Beth Harrison, et al.. (2018). Nipple-Invasive Primary Carcinomas: Clinical, Imaging, and Pathologic Features of Breast Carcinomas Originating in the Nipple. Archives of Pathology & Laboratory Medicine. 142(5). 598–605. 9 indexed citations
7.
Kuba, M. Gabriela, Susan C. Lester, Catherine S. Giess, et al.. (2017). Fibromatosis of the Breast. American Journal of Clinical Pathology. 148(3). 243–250. 15 indexed citations
8.
Martei, Yehoda M., Lydia E. Pace, Jane E. Brock, & Lawrence N. Shulman. (2017). Breast Cancer in Low- and Middle-Income Countries. Clinics in Laboratory Medicine. 38(1). 161–173. 81 indexed citations
9.
Tolaney, Sara M., David R. Ziehr, Hao Guo, et al.. (2016). Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients. The Oncologist. 22(1). 25–32. 70 indexed citations
10.
Freedman, Rachel A., Emily F. Stamell, Yasuaki Sagara, et al.. (2015). Modern Trends in the Surgical Management of Paget’s Disease. Annals of Surgical Oncology. 22(10). 3308–3316. 15 indexed citations
11.
Sagara, Yasuaki, William T. Barry, Melissa Anne Mallory, et al.. (2015). Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast. Annals of Surgical Oncology. 22(13). 4280–4286. 18 indexed citations
12.
Tolaney, Sara M., David R. Ziehr, Hao Guo, et al.. (2015). A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 33(15_suppl). 1080–1080. 3 indexed citations
13.
Tolaney, Sara M., Hao Guo, William T. Barry, et al.. (2014). A phase II study of tivantinib (ARQ-197) for metastatic triple-negative breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 1106–1106. 3 indexed citations
14.
Kansal, Kari J., Laura S. Dominici, Sara M. Tolaney, et al.. (2013). Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction. Breast Cancer Research and Treatment. 141(2). 255–259. 7 indexed citations
15.
Russo, Andrea, Nils D. Arvold, Andrzej Niemierko, et al.. (2013). Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Research and Treatment. 140(2). 353–361. 34 indexed citations
16.
Margalit, Danielle N., Meera Sreedhara, Yu‐Hui Chen, et al.. (2012). Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or Mastectomy. Annals of Surgical Oncology. 20(3). 811–818. 45 indexed citations
17.
Hornick, Jason L., et al.. (2011). A Comparison of Equivocal Immunohistochemical Results With Anti-HER2/neu Antibodies A0485 and SP3 With Corresponding FISH Results in Routine Clinical Practice. American Journal of Clinical Pathology. 135(6). 845–851. 21 indexed citations
18.
Halasz, Lia M., Meera Sreedhara, Yu‐Hui Chen, et al.. (2011). Improved Outcomes of Breast-Conserving Therapy for Patients With Ductal Carcinoma in Situ. International Journal of Radiation Oncology*Biology*Physics. 82(4). e581–e586. 28 indexed citations
19.
Brock, Jane E., Antonio R. Pérez‐Atayde, Harry P. Kozakewich, et al.. (2005). Cytogenetic Aberrations in Perineurioma. The American Journal of Surgical Pathology. 29(9). 1164–1169. 45 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Ferrari Breakdown of academic impact, for papers by Benita Kiat Tee Tan Breakdown of academic impact, for papers by Elizabeth M. Azzato Breakdown of academic impact, for papers by G. Schubert-Fritschle Breakdown of academic impact, for papers by Renjian Jiang Breakdown of academic impact, for papers by Mary Cianfrocca Breakdown of academic impact, for papers by Frank Peters Breakdown of academic impact, for papers by Sung Hoon Sim Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Dimitri Korol
Rankless by CCL
2026